Cancer Prevention and Control

Researchers in the Cancer Prevention and Control program conduct population-based, transdisciplinary, practice-changing studies across the cancer control continuum from primary prevention through survivorship. Cross-cutting themes include behavior change; aging; diversity, health equity and inclusion; and guideline and policy development.

The program focuses on catchment area needs to improve:

• Disproportionately high incidence and mortality rates for specific cancers (e.g., tobacco-related, hematologic, pancreatic/hepatobiliary);
• Low screening rates, high smoking rates, low physical activity rates, and high obesity rates;
• The burden of cancer treatment-related toxicity and side effects;
• Cancer supportive care delivery;
• Inequity and exclusion among individuals who are older, rural residents, who are Black, Latino, Deaf, or identify as a sexual/gender minority.

The specific aims of the CPC program are:

• To identify novel, effective interventions to reduce cancer risk in individuals with high probability for a cancer diagnosis.
• To develop innovative, effective supportive care therapies for patients, survivors, and caregivers to mitigate the toxicities and side effects caused by cancer and its treatments.
• To develop cutting-edge, effective system-level supportive care interventions for oncology practices and health care systems to improve outcomes for patients.

With a highly collaborative membership, the CPC also has strong expertise in clinical trial design and execution — and facilitates clinical research as a National Cancer Institute Community Oncology Research Program (NCORP) base, one of only two such research bases at an academic medical center in the U.S.

Program Leaders

Members